1osz: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:1osz.png|left|200px]] | [[Image:1osz.png|left|200px]] | ||
{{STRUCTURE_1osz| PDB=1osz | SCENE= }} | {{STRUCTURE_1osz| PDB=1osz | SCENE= }} | ||
===MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND AN (L4V) MUTANT OF THE VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN=== | ===MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND AN (L4V) MUTANT OF THE VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN=== | ||
{{ABSTRACT_PUBMED_9707600}} | {{ABSTRACT_PUBMED_9707600}} | ||
==About this Structure== | ==About this Structure== | ||
[[1osz]] is a 3 chain structure of [[Beta-2 microglobulin]] with sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1OSZ OCA]. | |||
==See Also== | |||
*[[Beta-2 microglobulin|Beta-2 microglobulin]] | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:009707600</ref><ref group="xtra">PMID:010422827</ref><ref group="xtra">PMID:012479822</ref><references group="xtra"/> | ||
[[Category: Mus musculus]] | [[Category: Mus musculus]] | ||
[[Category: Chang, H C.]] | [[Category: Chang, H C.]] | ||
| Line 35: | Line 26: | ||
[[Category: Wang, J H.]] | [[Category: Wang, J H.]] | ||
[[Category: Witte, T.]] | [[Category: Witte, T.]] | ||
[[Category: Mhc | [[Category: Mhc-peptide complex]] | ||
[[Category: Thymic selection]] | [[Category: Thymic selection]] | ||
[[Category: Transmembrane protein]] | [[Category: Transmembrane protein]] | ||
Revision as of 09:47, 27 July 2012
MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND AN (L4V) MUTANT OF THE VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN
Template:ABSTRACT PUBMED 9707600
About this Structure
1osz is a 3 chain structure of Beta-2 microglobulin with sequence from Mus musculus. Full crystallographic information is available from OCA.
See Also
Reference
- Ghendler Y, Teng MK, Liu JH, Witte T, Liu J, Kim KS, Kern P, Chang HC, Wang JH, Reinherz EL. Differential thymic selection outcomes stimulated by focal structural alteration in peptide/major histocompatibility complex ligands. Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):10061-6. PMID:9707600
- Krebs S, Rognan D, Lopez de Castro JA. Long-range effects in protein--ligand interactions mediate peptide specificity in the human major histocompatibilty antigen HLA-B27 (B*2701). Protein Sci. 1999 Jul;8(7):1393-9. PMID:10422827 doi:10.1110/ps.8.7.1393
- Achour A, Michaelsson J, Harris RA, Odeberg J, Grufman P, Sandberg JK, Levitsky V, Karre K, Sandalova T, Schneider G. A structural basis for LCMV immune evasion: subversion of H-2D(b) and H-2K(b) presentation of gp33 revealed by comparative crystal structure.Analyses. Immunity. 2002 Dec;17(6):757-68. PMID:12479822
